SELLAS Life Sciences Group, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
SELLAS Life Sciences Group, Inc. (SLS) reported Adjustments to Additional Paid in Capital, Warrant Issued of -$5.04 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-13.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2020-03-13
- SELLAS Life Sciences Group, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2018-12-31 was $0.00.
- SELLAS Life Sciences Group, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2018-09-30 was -$10.08M.
- SELLAS Life Sciences Group, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2018-06-30 was $2.45M.
- SELLAS Life Sciences Group, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2018-03-31 was $2.59M, a 75.02% decline year-over-year.
- SELLAS Life Sciences Group, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2018 was -$5.04M.
- SELLAS Life Sciences Group, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2016 was -$9.89M.
- SELLAS Life Sciences Group, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2015 was -$10.30M.
- SELLAS Life Sciences Group, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2011 was -$12.71M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month as first filed | Adjustments to Additional Paid in Capital, Warrant Issued 12 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month as first filed |
|---|---|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -$10.08M derived: sum of 2 quarters · filed 2020-03-13 | -$7.63M derived: sum of 3 quarters · filed 2020-03-13 | -$5.04M 10-K · filed 2020-03-13 | $5.04M 10-K · filed 2019-03-22 | |
| 2018-09-30 | -$10.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$7.63M derived: sum of 2 quarters · filed 2019-11-14 | -$5.04M 10-Q · filed 2019-11-14 | $5.04M 10-Q · filed 2018-11-14 | ||
| 2018-06-30 | $2.45M 10-Q · filed 2019-08-14 | $5.04M 10-Q · filed 2019-08-14 | ||||
| 2018-03-31 | $2.59M 10-Q · filed 2019-05-15 | |||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | $10.36M 10-Q · filed 2017-11-09 | -$9.41M derived: sum of 4 quarters · filed 2017-11-09 | ||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $10.36M 10-Q · filed 2017-08-14 | -$9.41M derived: sum of 3 quarters · filed 2017-08-14 | -$5.12M derived: sum of 4 quarters · filed 2017-08-14 | ||
| 2017-03-31 | $10.36M 10-Q · filed 2017-05-10 | -$9.41M derived: sum of 2 quarters · filed 2017-05-10 | -$5.12M derived: sum of 3 quarters · filed 2017-05-10 | -$5.12M derived: sum of 4 quarters · filed 2017-05-10 | ||
| 2016-12-31 | -$19.77M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -$15.48M derived: sum of 2 quarters · filed 2017-03-15 | -$15.48M derived: sum of 3 quarters · filed 2017-03-15 | -$9.89M 10-K · filed 2017-03-15 | ||
| 2016-09-30 | $4.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $4.30M derived: sum of 2 quarters · filed 2016-11-09 | $9.89M 10-Q · filed 2016-11-09 | |||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $5.59M 10-Q · filed 2016-08-09 | ||||
| 2016-03-31 | $5.59M 10-Q · filed 2016-05-10 | |||||
| 2015-12-31 | -$10.30M 10-K · filed 2017-03-15 | |||||
| 2012-12-31 | -$7.29M 8-K · filed 2015-12-04 | |||||
| 2011-12-31 | -$12.71M 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |